Skip to content


Annals of General Psychiatry

Open Access

Psychiatric trainees' opinions toward novel antipsychotics

  • BJ Havaki-Kontaxaki1,
  • VP Kontaxakis1,
  • KG Paplos1,
  • D Katritsis1 and
  • AD Rabavilas1
Annals of General Hospital Psychiatry20032(Suppl 1):S111

Received: 1 November 2003

Published: 23 December 2003


SchizophreniaClozapineRisperidoneOlanzapineConvenience Sample


The aim of this study is to investigate opinions and prescribing practices towards atypical antipsychotics (AA) among psychiatric trainees in Greece.

Material and Methods

A study of a convenience sample of Greek psychiatric trainees (n = 160) was conducted, in 2001. Their mean age was 32.8 (± 2.7) years. There were 82 male (51%) and 78 female (49%). 111 trainees (69%) were working at National Health System and 49 (31%) at University Departments. All respondents completed a 10-items questionnaire that measures opinions and prescribing practices toward novel antipsychotics.


The most often used AA were: risperidone (98.7%), olanzapine (98.1%), clozapine (79.2%), quetiapine (61.0%), sertindole (1.9%). Ziprasidone and amisulpride were not yet available in Greek market during the study time period. Combination therapy with atypical and conventional antipsychotics (63.3%) as well as monotherapy with atypical antipsychotics (24.1%) were considered as treatments of choice for treatment resistant schizophrenia (TRS). The AA more often used as monotherapy in treatment resistant schizophrenia were clozapine (72.5%), risperidone (18.1%) and olanzapine (8.8%).


The most commonly used AA were risperidone and olanzapine. Clozapine monotherapy as well as combination therapy with atypical and conventional antipsychotics were considered as treatments of choice for TRS.

Authors’ Affiliations

Department of Psychiatry, University of Athens, Eginition Hospital, Athens, Greece


© The Author(s) 2003